HIV Treatment Advances Highlight SPT Week in Review

Top news of the week from Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/hiv-treatment-advances-highlight-spt-week-in-revie" target="_blank">View the story "HIV Treatment Advances Highlight SPT Week in Review" on Storify</a>]

Related Videos
View All
Related Content

Pharmacists Can Help Mitigate Pre-Exposure Prophylaxis Drug Concerns With Education, Adherence Assistance

February 1st 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

FDA Acknowledges Need for New Regulatory Framework for Cannabidiol Products

February 1st 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

NACDS Conference: TikTok May Become the Next Big Health Search Engine

January 31st 2023

Trial of Lisocabtagene Maraleucel Meets Primary Endpoint in Relapsed, Refractory Chronic Lymphocytic Leukemia

January 31st 2023

Pharmacists Can Help Mitigate Pre-Exposure Prophylaxis Drug Concerns With Education, Adherence Assistance

February 1st 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

FDA Acknowledges Need for New Regulatory Framework for Cannabidiol Products

February 1st 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

NACDS Conference: TikTok May Become the Next Big Health Search Engine

January 31st 2023

Trial of Lisocabtagene Maraleucel Meets Primary Endpoint in Relapsed, Refractory Chronic Lymphocytic Leukemia

January 31st 2023

Pharmacists Can Help Mitigate Pre-Exposure Prophylaxis Drug Concerns With Education, Adherence Assistance

February 1st 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

FDA Acknowledges Need for New Regulatory Framework for Cannabidiol Products

February 1st 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

NACDS Conference: TikTok May Become the Next Big Health Search Engine

January 31st 2023

Trial of Lisocabtagene Maraleucel Meets Primary Endpoint in Relapsed, Refractory Chronic Lymphocytic Leukemia

January 31st 2023
About Us
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.